Fly posting

I'm presenting a couple of posters at the International Society of Pharmacovigilance Conference this week. One is concerned with possible neuropsychiatric reactions to varenicline, and the other uses the DoTS ADR classification system to analyse reports of angioedema with angiotensin-II receptor antagonists. Further details at the links in the text.

Pharmacovigilance is for everyone

Here is a link to a Pharmaceutical Journal article about pharmacovigilance a colleague and I wrote. Dr Davies was the lead author of the recent PLoS One paper on in-patient adverse drug reactions. It's slightly parochial, being a response to Royal Pharmaceutical Society of Great Britain report on drug safety,…

The adverse effects of neuraminidase inhibitors

I have a new article in The Pharmaceutical Journal published with a colleague Dr Deborah Layton looking at the neuraminidase inhibitors oseltamivir and zanamivir. Cox A, Layton D. Adverse drug reactions: Neuraminidase inhibitors: widespread use for influenza may reveal more adverse effects. The Pharmaceutical Journal 2009; 282:621-622 The neuraminidase inhibitors…